Trump administration proposes cutting FDA budget by 5.5%
MSN/Reuters
Mon, 06/2/25 - 11:47 pm
FDA
user fees
Donald Trump
Marty Makary
Lyra Therapeutics stock soars on positive Phase 3 trial results
Investing.com
Mon, 06/2/25 - 11:41 pm
Lyra Therapeutics
clinical trials
chronic rhinosinusitis
LYR-210
Kymera, with new data, takes early step toward a Dupixent-like pill
BioPharma Dive
Mon, 06/2/25 - 11:33 pm
Kymera
autoimmune diseases
clinical trials
Dupixent
protein degradation
Elon Musk’s Neuralink raises $650 million in fresh capital
CNBC
Mon, 06/2/25 - 11:32 pm
Neuralink
Elon Musk
funding
Medtech
ASCO25: Trodelvy and Keytruda to become new standard of care for frontline TNBC
Clinical Trials Arena
Mon, 06/2/25 - 11:24 pm
ASCO 2025
Gilead Sciences
Merck
Trodelvy
Keytruda
triple negative breast cancer
June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Mon, 06/2/25 - 11:47 am
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
MSN/Reuters
Mon, 06/2/25 - 11:45 am
ASCO 2025
Gilead Sciences
glioblastoma
cell therapy
CAR-T
ASCO25: Novartis hopes Scemblix becomes new standard for CML-CP
Clinical Trials Arena
Mon, 06/2/25 - 11:39 am
ASCO 2025
Novartis
Scemblix
chronic myeloid leukemia
Sanofi expands rare immunology portfolio with Blueprint buyout
Yahoo/Benzinga
Mon, 06/2/25 - 11:33 am
Sanofi
M&A
Blueprint Medicines
immunology
Moderna's next-gen COVID shot gets FDA backing with some limitations
Fierce Pharma
Mon, 06/2/25 - 11:30 am
Moderna Therapeutics
FDA
COVID-19
vaccines
mNEXSPIKE
Novartis' Pluvicto shown to slow prostate cancer in earlier setting
Yahoo/Reuters
Mon, 06/2/25 - 11:29 am
Novartis
radiotherapy
Pluvicto
prostate cancer
clinical trials
ASCO: AstraZeneca's oral SERD tied to 56% PFS benefit in phase 3 breast cancer trial
Fierce Biotech
Mon, 06/2/25 - 11:26 am
AstraZeneca
ASCO 2025
Camizestrant
clinical trials
breast cancer
ASCO: Amgen takes victory lap as Imdelltra prolongs life in small cell lung cancer
Fierce Pharma
Mon, 06/2/25 - 11:18 am
ASCO 2025
Amgen
Imdelltra
small cell lung cancer
Regeneron pens $2B pact for Hansoh's potential obesity rival to Lilly's Zepbound
Fierce Biotech
Mon, 06/2/25 - 11:17 am
Regeneron
Hansoh
obesity
Eli Lilly
HS-20094
ASCO25: J&J’s Carvykti shows strong efficacy across multiple myeloma risk groups
Clinical Trials Arena
Mon, 06/2/25 - 11:15 am
ASCO 2025
JNJ
Carvykti
cell therapy
Multiple Myeloma
The MAHA agenda won’t include expanding GLP-1 coverage — for now
Pharma Voice
Mon, 06/2/25 - 11:13 am
Donald Trump
Robert F Kennedy Jr.
obesity
GLP-1 agonists
Medicaid
Medicare
Vera drug scores in closely watched study in rare kidney disease
BioPharma Dive
Mon, 06/2/25 - 11:11 am
Vera Therapeutics
IgA nephropathy
clinical trials
atacicept
ASCO25: Johnson & Johnson reports data from Phase I trial of prostate cancer drug
Clinical Trials Arena
Mon, 06/2/25 - 11:09 am
JNJ
clinical trials
ASCO 2025
pasritamig
bispecific antibodies
metastatic castration-resistant prostate cancer
Diakonos Oncology secures $20m for Phase II trial of glioblastoma treatment
Clinical Trials Arena
Mon, 06/2/25 - 11:07 am
Diakonos Oncology
funding
dubodencel
glioblastoma
Sales Firm In Orlando Is Seeking Candidates With Pharmaceutical Sales Experience For Entry Level Sales Positions!!! - The White Label Firm - Alafaya, Florida, United States
Mon, 06/2/25 - 11:04 am

Pages